Opening question: When a research-peptide catalog flashes a PSI-MI / MI ontology code, an “IMEx interaction” badge, or a molecular-interaction evidence screenshot next to a vial SKU, how do you tell interaction-data standards literacy from proof that the peptide is cleared for people?
Short answer: open the HUPO PSI Molecular Interactions workgroup page and skim the published PSI-MI controlled vocabulary (OBO). The workgroup focuses on improving annotation and representation of molecular interaction data and making that data accessible in common formats (PSI-MI XML / MITAB). That is proteomics interoperability literacy. It is not a drug-approval pathway.
A practical PSI-MI checklist when ads lean on interaction graphics:
- What the workgroup builds: The Molecular Interactions page states the group concentrates on better annotation/representation of interaction data in journals, websites, and databases, and on accessibility via a common standard data format so downloads from multiple sources can be combined with a single parser. Outcomes named on the page include data-standard guidelines, the IMEx (International Molecular Interaction Exchange) consortium, and MIMIx (Minimum Information about a Molecular Interaction experiment).
- Formats vs product claims: PSI-MI XML / MITAB describe how interaction records are serialized. Seeing “PSI-MI,” “MITAB,” or an MI term ID beside a peptide SKU means someone is speaking the interaction-exchange dialect. It does not mean the vial was shown safe or effective in people.
- Evidence-type vocabulary is not clinical grade: The PSI-MI OBO vocabulary catalogs interaction detection methods, participant identification methods, and related annotation terms used by databases. An MI code next to marketing copy is experimental-annotation literacy—distinct from STRING network scores or BioGRID hit lists, and still not human-use clearance.
- IMEx / MIMIx are sharing rules: IMEx and MIMIx address consistent exchange and minimum reporting for interaction experiments. They help curators and databases align records; they do not certify a research-chemical catalog as medicine.
- What to open next: Identify whether the ad shows a format name, an MI ontology term, or an IMEx-style database screenshot, then ask whether the seller is teaching interaction-data standards or implying “interaction-proven” equals ready for people.
None of those steps turns a laboratory research listing into an approved medicine. Company research-only catalogs document laboratory intent and paperwork such as certificates of analysis; they do not create human-use approval. For company facts only—not clinical evidence—Apollo Peptides states products are for laboratory research only, not for human or veterinary use, and describes third-party testing with certificates of analysis.
Bottom line: Use HUPO PSI-MI pages to understand how molecular interaction records are standardized for exchange, then ask whether the ad is teaching that distinction or implying a research peptide is medically meaningful because an MI evidence code looks rigorous. That habit changes what you notice in catalogs—it is not advice to buy, inject, or dose any peptide.
By The Everyday Brief · AI-assisted editorial. Drafted with AI research assistance; claims checked against the HUPO PSI Molecular Interactions page and the PSI-MI OBO vocabulary file (fetched 2026-09-28 PT). No invented studies, quotes, or dosing. Not medical or legal advice.
Sources
1. HUPO PSI — Molecular Interactions workgroup
2. HUPO PSI — PSI-MI controlled vocabulary (OBO)
3. HUPO PSI — Molecular Interactions group listing
4. Apollo Peptides (company facts only)
Related reading
How to use STRING when peptide ads flash protein interaction networks
What BioGRID interaction records mean when peptide ads flash BioGRID hits
How to use UniProt and NCBI Protein when peptide ads say “sequence verified”